Otsuka (United States)

Recent papers from Otsuka (United States)

1. Sibeprenlimab in IgA Nephropathy — Final Phase 3 Trial AnalysisNew England Journal of Medicine · 2026
2. Brexpiprazole for Individual Agitation Symptoms in Alzheimer’s Dementia: A Caregiver-Centered Post Hoc AnalysisNeurology and Therapy · 2026
3. Patient Perspectives on Their Home Peritoneal Dialysis Experience: A Qualitative Study.2026
4. Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trialsThe Lancet · 2025
5. Mediation Analysis of Urine Osmolality and Response to Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc AssessmentNephrology · 2026
6. Clinically Meaningful Within-Patient Change in Core Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents Treated With Centanafadine: Results From Two Phase 3 Randomized Clinical TrialsJournal of Attention Disorders · 2026
7. Treatment Preferences of Physicians of Pediatric Patients with Attention-Deficit/Hyperactivity Disorder in the United States and Canada: A Discrete Choice ExperimentNeurology and Therapy · 2026
8. Multicenter, Randomized, Double-Blind, Placebo-Controlled Study on the Effect of Oral Tolvaptan on Left Ventricular Dilation and Function in Patients With Heart Failure and Systolic DysfunctionJournal of the American College of Cardiology · 2007
9. Real-world Tildrakizumab Effectiveness and Drug Survival: A Cohort Study in the PPD CorEvitas Psoriasis RegistryDermatology and Therapy · 2026
10. Efficacy and Safety of Sibeprenlimab in IgA Nephropathy: Interim Analysis of the China Cohort in the Phase 3 VISIONARY TrialClinical Kidney Journal · 2026
11. Brexpiprazole for anxiety symptoms in people living with schizophrenia: a plain language summaryExpert Review of Clinical Pharmacology · 2026
12. Aripiprazole once-monthly for patients diagnosed with bipolar I disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmedJournal of Affective Disorders · 2026
13. Adoption of prescription digital therapeutics (PDTs) for mental health: a systematic review of interest holder barriers and facilitatorsBMC Digital Health · 2026
14. Respiratory waveform variability during oral feeding in preterm infantsInternational Journal of Medical Engineering and Informatics · 2026
15. The Economic Impact of Cumulative Metabolic Comorbidity Burden in Schizophrenia: A Claims-Based Analysis of Medical Costs in the United StatesNeurology and Therapy · 2026
16. Humoral Response to COVID-19 Vaccines and Infection During Sibeprenlimab Treatment of IgA NephropathyClinical Journal of the American Society of Nephrology · 2026
17. Clinical Characteristics as Predictors of Healthcare Resource Utilization in Immunoglobulin A Nephropathy: A Retrospective Database StudyJournal of health economics and outcomes research · 2026
18. Brexpiprazole With Antidepressants for Agitation in Alzheimer’s Dementia: Post Hoc AnalysisAmerican Journal of Geriatric Psychiatry · 2026
19. A phase 1, multicenter, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of SBO-154 in subjects with advanced solid tumors.Journal of Clinical Oncology · 2026
20. Exploring Transdiagnostic Mechanisms of Externalizing Psychopathology among Youths: A Longitudinal, Person-Centered ApproachClinical Psychological Science · 2026